small molecule therapeutic for Huntington's disease (Avergen)

N/A

Report date: 2025/01/26 17:05:26
NME

Base Information

Drug Namesmall molecule therapeutic for Huntington's disease (Avergen)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHuntingtin modulators
TargetsHuntingtin
Therapy Area/IndicationsHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAvergen Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAvergen Ltd
Inactive CompaniesN/A
Active IndicationsHuntington Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A